AVGR
Avinger, Inc.
Set alert
52-week range unavailable
- YTD
- -42.05%
- 1 year
- -83.66%
- Open
- 0.5561
- Prev close
- 0.474
- Mkt cap
- 4.64M
- Vol
- 2.59M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4633
- High
- 0.6058
- Forward P/E
- -1.23
- Beta
- 1.16
- Short ratio
- 0.22
- Inst. own
- 2.84%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.79086
- 200-d avg
- 1.82
- 1y target
- 5.00
Key statistics
- Market cap
- 4.64M
- Enterprise value
- -1.19M
- Trailing P/E
- 0.00
- Forward P/E
- -1.23
- PEG ratio
- 0.00
- Price / sales
- 0.62
- Price / book
- 0.00
- EPS (TTM)
- -8.76
- Beta
- 1.16
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -260.86%
- Revenue (TTM)
- 7.43M
- Revenue growth
- -9.50%
- Free cash flow
- -9.95M
- Total cash
- 8.81M
- Total debt
- 5.75M
- Return on equity
- -3332.59%
- Shares outstanding
- 3.20M
- Short % of float
- 6.10%
- 50-day average
- 0.79086
- 200-day average
- 1.82
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -2.03 | -1.82 | +0.21 | +10.34% |
| Aug 8, 2024 | Jun 1, 2024 | -0.43 | -2.82 | -2.39 | -555.81% |
| May 15, 2024 | Mar 1, 2024 | -1.35 | -2.49 | -1.14 | -84.44% |
| Mar 20, 2024 | Dec 1, 2023 | 0.64 | -3.93 | -4.57 | -714.06% |
| Oct 26, 2023 | Sep 1, 2023 | -2.85 | -2.92 | -0.07 | -2.46% |
| Jul 27, 2023 | Jun 1, 2023 | -7.35 | -8.85 | -1.50 | -20.41% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 21, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | main | Buy | Buy |
About Avinger, Inc.
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- avinger.com
News
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Dow Edges Higher; US Weekly Jobless Claims Increase
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
- Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Your note
Sign in to keep a note on AVGR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CULLEN JAMES G | Director | Stock Award(Grant) | Jan 10, 2024 | 29,895 |
| ELIAS TAMARA N. M.D. | Director | Stock Award(Grant) | Jan 10, 2024 | 29,962 |
| MCELWEE JAMES B | Director | Stock Award(Grant) | Jan 10, 2024 | 29,895 |
| PATEL HIMANSHU T | Chief Technology Officer | Stock Award(Grant) | Jan 17, 2024 | 41,277 |
| SOINSKI JEFFREY MARTIN | Chief Executive Officer | Stock Award(Grant) | Jan 17, 2024 | 58,955 |
| SUBAINATI NABEEL PAUL | Officer | Sale | Mar 22, 2023 | 85,672 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 2.45% | 81,000 | 117.45K | Sep 29, 2024 |
| UBS Group AG | 0.79% | 26,174 | 37.95K | Sep 29, 2024 |
| Vanguard Group Inc | 0.72% | 23,802 | 34.51K | Sep 29, 2024 |
| Blackrock Inc. | 0.15% | 4,897 | 7.10K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.12% | 4,125 | 5.98K | Sep 29, 2024 |
| City State Bank | 0.01% | 225 | 326 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.72% | 23,802 | 34.51K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.21% | 6,939 | 10.06K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.09% | 2,859 | 4.14K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 513 | 743 | Oct 30, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 34 | 49 | Sep 29, 2024 |